What MyAccess Clinics does

MyAccess Clinics operates as Alternaleaf, a UK-based private online medical cannabis clinic registered as Montu Group UK Ltd (company number 14043081) and regulated by the Care Quality Commission. The company runs a direct-to-consumer telemedicine model in which patients complete a 30-second online eligibility pre-screen, book video consultations with specialist clinicians for conditions including chronic pain, mental health, neurological disorders, and women's health, and receive personalized prescriptions with no GP referral required. Since UK medical cannabis was legalized in November 2018, the clinic has built a stated base of 200,000+ patients globally and 150,000+ in the UK, treating more than 50 conditions through 100+ medication options (flower, oil, vaporizer cartridges, edibles) delivered by a partner pharmacy network.

The underlying platform combines an online eligibility and appointment booking system with NHS medical records integration, video consultation infrastructure, and a partner pharmacy fulfillment chain that delivers medication directly to patients' doors with a bundled monthly free delivery. Technology is presented as a self-serve telemedicine stack with a mobile application (iOS and Android) and an external-facing AI chatbot presence via partnerships with ChatGPT, Google Gemini, Claude, and Perplexity used for patient acquisition rather than clinical decisioning. Headquarters are at 140 Wharfedale Road, Winnersh Triangle, Reading, with an 11-employee UK headcount.

Revenue is generated through two channels: a £5/month membership covering all required appointments and a £29 per-appointment pay-as-you-go option, with both including personalized treatment, monthly free delivery, and travel letters. Medication is billed separately by the partner pharmacy, with flower starting from £5/gram and total medication cost as low as £20/week. The company drives patient acquisition through Google Reviews (4.7 rating), Trustpilot, branded patient stories, a CannaVERSE educational blog, and widespread UK national media coverage including BBC, Telegraph, Daily Mail, City AM, and The Sun, supplemented by a May 2025 Censuswide survey of 500 UK doctors and out-of-home billboard advertising. The clinic received a CQC 'Requires improvement' rating in February 2026, indicating outstanding operational or clinical governance remediation work.

Name

MyAccess Clinics

Legal name

Montu Group UK Ltd

Website

https://myaccessclinics.co.uk

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Alternaleaf (MyAccess Clinics / Montu Group UK Ltd) is a UK CQC-regulated online medical cannabis clinic offering video consultations and home-delivered prescriptions for 50+ chronic conditions via a £5/month membership or £29 pay-as-you-go model.

Ownership category

akta.pro rank

Product category

Medical Cannabis Clinic Services

NAICS

Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

akta.pro secondary industries

Medical Cannabis Dispensaries (CRANAFAB), Medical Cannabis Delivery & Online Ordering (CRANAGAG)

Keywords

• Medical cannabis clinic
• Telemedicine consultations
• Chronic pain treatment
• Online healthcare services
• Private prescription services

Headquarters

HQ city

Winnersh, Reading

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Consultation Services: Service fees charged for medical cannabis consultations and appointments. Two pricing options: pay-as-you-go at £29 per appointment, or monthly membership at £5 per month covering all required appointments. No hidden fees with money-back guarantee if patient does not qualify.
2. Medication Sales (Partner Pharmacy): Prescription medication sold through partner pharmacy network. Medication forms include flower (dry herb vaporiser), oil, vaporiser cartridges, and edibles. Price of medication varies but can be as little as £20 per week. Flower starts from £5 per gram.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

MyAccess Clinics, operating as Alternaleaf, provides private online medical cannabis consultations and prescriptions for UK patients with chronic pain, mental health, neurological, and women's health conditions. Services include a 30-second online eligibility pre-screen, video appointments with specialist clinicians, personalised treatment plans, and home delivery of prescribed medical cannabis (flower, oil, vaporiser cartridges, edibles) through partner pharmacies, with no GP referral required.

Product overview

Alternaleaf is a single-service online medical cannabis clinic platform. The core offering is private prescription consultations for medical cannabis, delivered via online video appointments. Services include eligibility screening, specialist clinician consultations, personalized prescription management, and free medication delivery across the UK. The company offers two payment models: a £5/month membership covering all required appointments, or £29 per appointment on a pay-as-you-go basis. Medication (flower, oil, vaporizer cartridges, edibles) is sourced from partner pharmacies with pricing starting from £20/week.

Differentiator

Problem solved

Functional benefit

Products and services

• Alternaleaf Medical Cannabis Clinic (Online Consultation and Prescription Service) UK-based private medical cannabis clinic offering online video consultations with specialist clinicians for chronic pain, mental health, neurological, and women's health conditions. Provides prescriptions, personalised treatment plans, and free home delivery of prescribed medical cannabis (flower, oil, vaporiser cartridges, edibles) through partner pharmacies, accessible without a GP referral.

Quantifiable outcome

• 83% of patients experience no negative side effects
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Partner PharmacycoreOthersPartner pharmacy network handles medication dispensing and delivery to patients. Medications are delivered directly to patients' doors with free monthly delivery included in membership. The pharmacy works closely with the clinic's specialist clinicians to fulfil prescriptions.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Zerenia Clinic (formerly The Medical Cannabis Clinics): UK private medical cannabis clinic providing specialist consultations and prescriptions. One of the early UK cannabis clinics and a direct competitor to Alternaleaf in the same patient segments.
• Lyphe Clinic: UK-based private medical cannabis clinic offering online consultations and prescriptions for chronic pain, mental health, and other conditions. Directly competes with Alternaleaf in the same D2C telemedicine-based model.
• Sapphire Medical Clinics: UK private medical cannabis clinic providing specialist consultations and prescriptions across multiple conditions. Competes directly with Alternaleaf for the same UK patient population.
• Leva Clinic: UK-based online medical cannabis clinic offering video consultations and prescriptions for chronic pain. Competitor in the same D2C telemedicine niche as Alternaleaf.
• Curaleaf Clinic (UK): UK arm of Curaleaf, a major global cannabis company, offering medical cannabis consultations and prescriptions online. Directly competes with Alternaleaf with similar condition coverage.
• Mamedica: UK-based medical cannabis clinic offering online consultations and prescriptions. Operates a similar DTC telehealth model targeting chronic pain, mental health, and neurological conditions.

Emerging players

• CB1 Medical: UK medical cannabis clinic offering specialist consultations and prescriptions. Smaller and emerging player targeting the same patient segments as Alternaleaf.
• Montu (Australia): Australian medical cannabis company operating the Alternaleaf brand under a related Montu Group structure. Operates a similar clinic + pharmacy dispensing model in Australia, providing evidence of the playbook's portability for UK expansion.

Broad incumbents

• Babylon Health: UK-based digital telehealth platform offering general practitioner consultations. While not a cannabis clinic, it shares the telehealth/D2C consultation model and could expand into condition-specific prescribing.

Others

• Zolta (formerly Grow Pharma): UK-based medical cannabis supplier and pharmacy provider. Functions as a potential supplier/partner in the cannabis dispensing chain rather than a direct clinic competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/myaccess-clinics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MyAccess Clinics